Comparison of the immunoassay method with the commercial and in-house LC-MS/MS methods for substance abuse in urine
Open Access
- 20 October 2023
- journal article
- research article
- Published by Walter de Gruyter GmbH in Turkish Journal of Biochemistry
- Vol. 49 (1) , 24-37
Abstract
Objectives: The aim of this study was to compare the analytical performance of the KIMS (kinetic interaction of microparticles in solution) immunochemical method with a validated in-house and a commercial LC-MS/MS method. Methods: The urine samples of the 100 subjects were included in the present study. The urine samples were analysed with Roche DAT immunochemical method based on KIMS method. In-house LC-MS/MS method was validated for 58 parameters according to the CLSI C62-A recommendations with the following parameters: matrix effect, lower limit of quantification (LLOQ), linearity, intra-day and inter-day precision and accuracy. Eureka Lab Division Drugs of Abuse kit was used as the commercial LC-MS/MS method. Results: The immunochemical method had a satisfactory performance with specificity, sensitivity and accuracy values above 80 % and met the DRUID recommendation except benzodiazepines. The sensitivity and specificity of the immunochemical method were between 97–100 % and 84–100 %, respectively (except for benzodiazepines). The bias obtained for THC-COOH, morphine and codeine parameters were −17.5, 24.6 and 43.6 between two LC-MS/MS methods. The commercial method had a tendency to have a negative bias except for cannabinoids. Conclusions: The analytical performance of the KIMS-based urine immunochemical method was found to be satisfactory for the intended use, except for benzodiazepines. The validated urine in-house LC-MS/MS method was found to be a good alternative for confirmation of substance abuse.Keywords
This publication has 42 references indexed in Scilit:
- Detection of drugs of abuse in simultaneously collected oral fluid, urine and blood from Norwegian drug driversForensic Science International, 2012
- Method Comparison of the Ortho Vitros Fusion 5,1 Chemistry Analyzer and the Roche COBAS Integra 400 for Urine Drug Screen Testing in the Emergency DepartmentJournal of Analytical Toxicology, 2012
- A Review of the Methods, Interpretation, and Limitations of the Urine Drug ScreenOrthopedics, 2011
- Analytical evaluation of a rapid on-site oral fluid drug testAnalytical and Bioanalytical Chemistry, 2010
- Using molecular similarity to highlight the challenges of routine immunoassay-based drug of abuse/toxicology screening in emergency medicineBMC Emergency Medicine, 2009
- Coca tea consumption causes positive urine cocaine assayEuropean Journal of Emergency Medicine, 2006
- Drug screening and confirmation by GC–MS: Comparison of EMIT II and Online KIMS against 10 drugs between US and England laboratoriesForensic Science International, 2006
- Urine Benzodiazepine Screening using Roche Online(R) KIMS Immunoassay with -Glucuronidase Hydrolysis and Confirmation by Gas Chromatography-Mass SpectrometryJournal of Analytical Toxicology, 2005
- Stable isotopically labeled internal standards in quantitative bioanalysis using liquid chromatography/mass spectrometry: necessity or not?Rapid Communications in Mass Spectrometry, 2005
- A Comparison of Roche Kinetic Interaction of Microparticles in Solution (KIMS(R)) Assay for Cannabinoids and GC-MS Analysis for 11-nor-9-Carboxy- 9-TetrahydrocannabinolJournal of Analytical Toxicology, 2001